CLINICAL TRIALS PROFILE FOR CARIPRAZINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for cariprazine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00488618 ↗ | Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania | Completed | Gedeon Richter Ltd. | Phase 2 | 2007-06-01 | This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo |
| NCT00488618 ↗ | Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania | Completed | Forest Laboratories | Phase 2 | 2007-06-01 | This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo |
| NCT00694707 ↗ | Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia | Completed | Gedeon Richter Ltd. | Phase 2 | 2008-06-30 | This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia. |
| NCT00694707 ↗ | Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia | Completed | Forest Laboratories | Phase 2 | 2008-06-30 | This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia. |
| NCT00839852 ↗ | A Study of Cariprazine in Patients With Chronic Stable Schizophrenia | Completed | Gedeon Richter Ltd. | Phase 2 | 2009-05-31 | This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia. |
| NCT00839852 ↗ | A Study of Cariprazine in Patients With Chronic Stable Schizophrenia | Completed | Forest Laboratories | Phase 2 | 2009-05-31 | This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia. |
| NCT00852202 ↗ | Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression | Completed | Gedeon Richter Ltd. | Phase 2 | 2009-06-30 | The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for cariprazine hydrochloride
Condition Name
Clinical Trial Locations for cariprazine hydrochloride
Trials by Country
Clinical Trial Progress for cariprazine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for cariprazine hydrochloride
Sponsor Name
